Back to Trades
Lee Sung
EVPChief Financial OfficerCIK 0001793200
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 2
- Active
- 2025–2026
Across 10 filings between 2025–2026, Lee Sung, EVP, Chief Financial Officer, has disclosed $10.5M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $3.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Jul 2 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Sell | $97.6K |
| Jun 29 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Sell | $3.2M |
| Jun 29 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Sell | $266.4K |
| Jun 8 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $72.2K |
| May 1 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $114.7K |
| Mar 18 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Sell | $306.7K |
| Mar 17 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Grant | $1.9M |
| Jan 6 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $535.8K |
| Jan 6 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Other | $0 |
| Dec 29 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Grant | $50.5K |
10 filings